{"entity":{"id":"nct07340814","kind":"trial","name":"A Long-term Follow-up Study of Patients Who Received MB-105","aka":[],"tldr":"An trial of MB-105 run by March Biosciences Inc, not yet recruiting.","summary":"A Long-term Follow-up Study of Patients Who Received MB-105 is an interventional study registered as NCT07340814 by March Biosciences Inc, with 40 participants planned, started 2026-02-27. Conditions recorded: Any Patient Treated With MB-105. Interventions recorded: MB-105.","status":"planned","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07340814","url":"https://clinicaltrials.gov/study/NCT07340814"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["mb-105"],"companies":["march-biosciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07340814","phase":"not-applicable","setting":"A Long-term Follow-up Study of Patients Who Received MB-105","sponsor":"March Biosciences Inc","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07340814/","neighbours":{"drug":[{"id":"mb-105","kind":"drug","name":"MB-105","route":"/drugs/mb-105/"}],"company":[{"id":"march-biosciences","kind":"company","name":"March Biosciences","route":"/companies/march-biosciences/"}]}}